BNP Paribas Maintains Neutral on AbbVie, Raises Price Target to $247
BNP Paribas analyst Navann Ty maintains AbbVie (NYSE: ABBV ) with a Neutral and raises the price target from $218 to $247.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.